Selected research
Market Analysis & Forecast
Global Poloxamer Market Analysis and Forecast 2026-2032
Market perspective
The global Poloxamer market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Poloxamer's global sales reached XX (Tons) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned BASF as the global sales leader, a title it has maintained for several consecutive years. Notably, BASF's performance in primary markets is also remarkable. In the Chinese market, sales were XX (Tons), a change of XX% from the previous year. In Europe, sales were XX (Tons), showing a year-on-year of XX%. In the US, sales were XX (Tons), a year-on-year change of XX%.
The major global manufacturers in the Poloxamer market include BASF, ADEKA, Croda, Nanjing Well, Hubei Hengshuo, Solvay and Merck KGaA, etc. In 2025, the top three vendors accounted for approximately % of the revenue.
Read the full market overview
In terms of production side, this report researches the Poloxamer production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.
In terms of consumption side, this report focuses on the sales of Poloxamer by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.
This report presents an overview of global market for Poloxamer, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Poloxamer, also provides the consumption of main regions and countries. Of the upcoming market potential for Poloxamer, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Poloxamer sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Poloxamer market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Poloxamer sales, projected growth trends, production technology, application and end-user industry.
Poloxamer Segment by Company
BASF
ADEKA
Croda
Nanjing Well
Hubei Hengshuo
Solvay
Merck KGaA
Poloxamer Segment by Type
Poloxamer 124
Poloxamer 184
Poloxamer 188
Poloxamer 338
Poloxamer 407
Others
Poloxamer Segment by Application
Cosmetics Industrial
Biologics
Pharmaceutical Industrial
Others
Poloxamer Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Poloxamer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Poloxamer and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Poloxamer.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Poloxamer production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 4: Sales (consumption), revenue of Poloxamer in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 5: Detailed analysis of Poloxamer manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Poloxamer sales, revenue, price, gross margin, and recent development, etc.
Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 11: China by type, by application, sales, and revenue for each segment.
Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 15: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Poloxamer 124
- Poloxamer 184
- Poloxamer 188
- Poloxamer 338
- Poloxamer 407
- Others
Applications
- Cosmetics Industrial
- Biologics
- Pharmaceutical Industrial
- Others
Companies covered
- BASF
- ADEKA
- Croda
- Nanjing Well
- Hubei Hengshuo
- Solvay
- Merck KGaA
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Poloxamer Market by Type
- 1.2.1 Global Poloxamer Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Poloxamer 124
- 1.2.3 Poloxamer 184
- 1.2.4 Poloxamer 188
- 1.2.5 Poloxamer 338
- 1.2.6 Poloxamer 407
- 1.2.7 Others
- 1.3 Poloxamer Market by Application
- 1.3.1 Global Poloxamer Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Cosmetics Industrial
- 1.3.3 Biologics
- 1.3.4 Pharmaceutical Industrial
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Poloxamer Market Dynamics
- 2.1 Poloxamer Industry Trends
- 2.2 Poloxamer Industry Drivers
- 2.3 Poloxamer Industry Opportunities and Challenges
- 2.4 Poloxamer Industry Restraints
3 Global Poloxamer Production Overview
- 3.1 Global Poloxamer Production Capacity (2021-2032)
- 3.2 Global Poloxamer Production by Region: 2021 VS 2025 VS 2032
- 3.3 Global Poloxamer Production by Region
- 3.3.1 Global Poloxamer Production by Region (2021-2026)
- 3.3.2 Global Poloxamer Production by Region (2027-2032)
- 3.3.3 Global Poloxamer Production Market Share by Region (2021-2032)
- 3.4 North America
- 3.5 Europe
- 3.6 China
- 3.7 Japan
4 Global Market Growth Prospects
- 4.1 Global Poloxamer Revenue Estimates and Forecasts (2021-2032)
- 4.2 Global Poloxamer Revenue by Region
- 4.2.1 Global Poloxamer Revenue by Region: 2021 VS 2025 VS 2032
- 4.2.2 Global Poloxamer Revenue by Region (2021-2026)
- 4.2.3 Global Poloxamer Revenue by Region (2027-2032)
- 4.2.4 Global Poloxamer Revenue Market Share by Region (2021-2032)
- 4.3 Global Poloxamer Sales Estimates and Forecasts 2021-2032
- 4.4 Global Poloxamer Sales by Region
- 4.4.1 Global Poloxamer Sales by Region: 2021 VS 2025 VS 2032
- 4.4.2 Global Poloxamer Sales by Region (2021-2026)
- 4.4.3 Global Poloxamer Sales by Region (2027-2032)
- 4.4.4 Global Poloxamer Sales Market Share by Region (2021-2032)
- 4.5 North America
- 4.6 Europe
- 4.7 China
- 4.8 Asia (Excluding China)
- 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
- 5.1 Global Poloxamer Revenue by Manufacturers
- 5.1.1 Global Poloxamer Revenue by Manufacturers (2021-2026)
- 5.1.2 Global Poloxamer Revenue Market Share by Manufacturers (2021-2026)
- 5.1.3 Global Poloxamer Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 5.2 Global Poloxamer Sales by Manufacturers
- 5.2.1 Global Poloxamer Sales by Manufacturers (2021-2026)
- 5.2.2 Global Poloxamer Sales Market Share by Manufacturers (2021-2026)
- 5.2.3 Global Poloxamer Manufacturers Sales Share Top 10 and Top 5 in 2025
- 5.3 Global Poloxamer Sales Price by Manufacturers (2021-2026)
- 5.4 Global Poloxamer Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 5.5 Global Poloxamer Key Manufacturers Manufacturing Sites & Headquarters
- 5.6 Global Poloxamer Manufacturers, Product Type & Application
- 5.7 Global Poloxamer Manufacturers Commercialization Time
- 5.8 Market Competitive Analysis
- 5.8.1 Global Poloxamer Market CR5 and HHI
- 5.8.2 2025 Poloxamer Tier 1, Tier 2, and Tier 3
6 Poloxamer Market by Type
- 6.1 Global Poloxamer Revenue by Type
- 6.1.1 Global Poloxamer Revenue by Type (2021-2032) & (US$ Million)
- 6.1.2 Global Poloxamer Revenue Market Share by Type (2021-2032)
- 6.2 Global Poloxamer Sales by Type
- 6.2.1 Global Poloxamer Sales by Type (2021-2032) & (Tons)
- 6.2.2 Global Poloxamer Sales Market Share by Type (2021-2032)
- 6.3 Global Poloxamer Price by Type
7 Poloxamer Market by Application
- 7.1 Global Poloxamer Revenue by Application
- 7.1.1 Global Poloxamer Revenue by Application (2021-2032) & (US$ Million)
- 7.1.2 Global Poloxamer Revenue Market Share by Application (2021-2032)
- 7.2 Global Poloxamer Sales by Application
- 7.2.1 Global Poloxamer Sales by Application (2021-2032) & (Tons)
- 7.2.2 Global Poloxamer Sales Market Share by Application (2021-2032)
- 7.3 Global Poloxamer Price by Application
8 Company Profiles
- 8.1 BASF
- 8.1.1 BASF Company Information
- 8.1.2 BASF Business Overview
- 8.1.3 BASF Poloxamer Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.1.4 BASF Poloxamer Product Portfolio
- 8.1.5 BASF Recent Developments
- 8.2 ADEKA
- 8.2.1 ADEKA Company Information
- 8.2.2 ADEKA Business Overview
- 8.2.3 ADEKA Poloxamer Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.2.4 ADEKA Poloxamer Product Portfolio
- 8.2.5 ADEKA Recent Developments
- 8.3 Croda
- 8.3.1 Croda Company Information
- 8.3.2 Croda Business Overview
- 8.3.3 Croda Poloxamer Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.3.4 Croda Poloxamer Product Portfolio
- 8.3.5 Croda Recent Developments
- 8.4 Nanjing Well
- 8.4.1 Nanjing Well Company Information
- 8.4.2 Nanjing Well Business Overview
- 8.4.3 Nanjing Well Poloxamer Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.4.4 Nanjing Well Poloxamer Product Portfolio
- 8.4.5 Nanjing Well Recent Developments
- 8.5 Hubei Hengshuo
- 8.5.1 Hubei Hengshuo Company Information
- 8.5.2 Hubei Hengshuo Business Overview
- 8.5.3 Hubei Hengshuo Poloxamer Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.5.4 Hubei Hengshuo Poloxamer Product Portfolio
- 8.5.5 Hubei Hengshuo Recent Developments
- 8.6 Solvay
- 8.6.1 Solvay Company Information
- 8.6.2 Solvay Business Overview
- 8.6.3 Solvay Poloxamer Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.6.4 Solvay Poloxamer Product Portfolio
- 8.6.5 Solvay Recent Developments
- 8.7 Merck KGaA
- 8.7.1 Merck KGaA Company Information
- 8.7.2 Merck KGaA Business Overview
- 8.7.3 Merck KGaA Poloxamer Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.7.4 Merck KGaA Poloxamer Product Portfolio
- 8.7.5 Merck KGaA Recent Developments
9 North America
- 9.1 North America Poloxamer Market Size by Type
- 9.1.1 North America Poloxamer Revenue by Type (2021-2032)
- 9.1.2 North America Poloxamer Sales by Type (2021-2032)
- 9.1.3 North America Poloxamer Price by Type (2021-2032)
- 9.2 North America Poloxamer Market Size by Application
- 9.2.1 North America Poloxamer Revenue by Application (2021-2032)
- 9.2.2 North America Poloxamer Sales by Application (2021-2032)
- 9.2.3 North America Poloxamer Price by Application (2021-2032)
- 9.3 North America Poloxamer Market Size by Country
- 9.3.1 North America Poloxamer Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 North America Poloxamer Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 North America Poloxamer Price by Country (2021-2032)
- 9.3.4 United States
- 9.3.5 Canada
10 Europe
- 10.1 Europe Poloxamer Market Size by Type
- 10.1.1 Europe Poloxamer Revenue by Type (2021-2032)
- 10.1.2 Europe Poloxamer Sales by Type (2021-2032)
- 10.1.3 Europe Poloxamer Price by Type (2021-2032)
- 10.2 Europe Poloxamer Market Size by Application
- 10.2.1 Europe Poloxamer Revenue by Application (2021-2032)
- 10.2.2 Europe Poloxamer Sales by Application (2021-2032)
- 10.2.3 Europe Poloxamer Price by Application (2021-2032)
- 10.3 Europe Poloxamer Market Size by Country
- 10.3.1 Europe Poloxamer Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 10.3.2 Europe Poloxamer Sales by Country (2021 VS 2025 VS 2032)
- 10.3.3 Europe Poloxamer Price by Country (2021-2032)
- 10.3.4 Germany
- 10.3.5 France
- 10.3.6 U.K.
- 10.3.7 Italy
- 10.3.8 Netherlands
11 China
- 11.1 China Poloxamer Market Size by Type
- 11.1.1 China Poloxamer Revenue by Type (2021-2032)
- 11.1.2 China Poloxamer Sales by Type (2021-2032)
- 11.1.3 China Poloxamer Price by Type (2021-2032)
- 11.2 China Poloxamer Market Size by Application
- 11.2.1 China Poloxamer Revenue by Application (2021-2032)
- 11.2.2 China Poloxamer Sales by Application (2021-2032)
- 11.2.3 China Poloxamer Price by Application (2021-2032)
12 Asia (Excluding China)
- 12.1 Asia Poloxamer Market Size by Type
- 12.1.1 Asia Poloxamer Revenue by Type (2021-2032)
- 12.1.2 Asia Poloxamer Sales by Type (2021-2032)
- 12.1.3 Asia Poloxamer Price by Type (2021-2032)
- 12.2 Asia Poloxamer Market Size by Application
- 12.2.1 Asia Poloxamer Revenue by Application (2021-2032)
- 12.2.2 Asia Poloxamer Sales by Application (2021-2032)
- 12.2.3 Asia Poloxamer Price by Application (2021-2032)
- 12.3 Asia Poloxamer Market Size by Country
- 12.3.1 Asia Poloxamer Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 Asia Poloxamer Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 Asia Poloxamer Price by Country (2021-2032)
- 12.3.4 Japan
- 12.3.5 South Korea
- 12.3.6 India
- 12.3.7 Australia
- 12.3.8 Taiwan
- 12.3.9 Southeast Asia
13 South America, Middle East and Africa
- 13.1 SAMEA Poloxamer Market Size by Type
- 13.1.1 SAMEA Poloxamer Revenue by Type (2021-2032)
- 13.1.2 SAMEA Poloxamer Sales by Type (2021-2032)
- 13.1.3 SAMEA Poloxamer Price by Type (2021-2032)
- 13.2 SAMEA Poloxamer Market Size by Application
- 13.2.1 SAMEA Poloxamer Revenue by Application (2021-2032)
- 13.2.2 SAMEA Poloxamer Sales by Application (2021-2032)
- 13.2.3 SAMEA Poloxamer Price by Application (2021-2032)
- 13.3 SAMEA Poloxamer Market Size by Country
- 13.3.1 SAMEA Poloxamer Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 13.3.2 SAMEA Poloxamer Sales by Country (2021 VS 2025 VS 2032)
- 13.3.3 SAMEA Poloxamer Price by Country (2021-2032)
- 13.3.4 Brazil
- 13.3.5 Argentina
- 13.3.6 Chile
- 13.3.7 Colombia
- 13.3.8 Peru
- 13.3.9 Saudi Arabia
- 13.3.10 Israel
- 13.3.11 UAE
- 13.3.12 Turkey
- 13.3.13 Iran
- 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
- 14.1 Poloxamer Value Chain Analysis
- 14.1.1 Poloxamer Key Raw Materials
- 14.1.2 Raw Materials Key Suppliers
- 14.1.3 Manufacturing Cost Structure
- 14.1.4 Poloxamer Production Mode & Process
- 14.2 Poloxamer Sales Channels Analysis
- 14.2.1 Direct Comparison with Distribution Share
- 14.2.2 Poloxamer Distributors
- 14.2.3 Poloxamer Customers
15 Concluding Insights
16 Appendix
- 16.1 Reasons for Doing This Study
- 16.2 Research Methodology
- 16.3 Research Process
- 16.4 Authors List of This Report
- 16.5 Data Source
- 16.5.1 Secondary Sources
- 16.5.2 Primary Sources
- 16.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst